AB 26. Comparison of pharmacokinetics of Moxifloxacin between patients with drug-resistant and multi-drug resistant pulmonary tuberculosis

BACKGROUND: Moxifloxacin is a potent bactericidal and sterilizing antitubercular drug that is currently used as part of the therapeutic regimen in cases of drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB). According to previous reports rifampicin reduces Moxifloxacin levels by 30...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Manika, Katerina, Chatzika, Kalliopi, Papaioannou, Maria, Kontou, Paschalina, Zarogoulidis, Konstantinos, Kioumis, Ioannis
Формат: Artigo
Язык:Inglês
Опубликовано: Pioneer Bioscience Publishing Company 2012
Предметы:
Abstract
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537437/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s026
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы